CTRC at the University of Texas Health Science Center

San Antonio, Texas 78229

0 studies enrolling now · 2 studies all time

What they study most

Advanced Breast Cancer, Advanced Malignant Solid Tumors, Breast Neoplasms, Tumors

Studies at this site

• First-in-Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Mirvetuximab Soravtansine in Adults With Ovarian Cancer and Other Folate Receptor 1 (FOLR1)-Positive Solid Tumors — Completed
• A Phase 1/2 Study of HKI-272 (Neratinib) in Combination With Paclitaxel (Taxol) in Subjects With Solid Tumors and Breast Cancer — Completed